MESA LABORATORIES INC /CO/
About MESA LABORATORIES INC /CO/
Mesa Laboratories Inc manufactures life sciences tools and critical quality control solutions. It operates in four divisions: i) Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. ii) Clinical Genomics division develops, manufactures, and sells sensitive, low-cost, high-throughput genetic analysis tools and related consumables. iii) The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. iv) The Calibration Solutions division develops, manufactures, sells, and services quality control products.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2026
- $249.1M
- Net income
- $6.7M
- Total assets
- $427.7M
- Market cap
- $574.0M
- Gross margin
- 63.5%
- Operating margin
- 7.4%
- Net margin
- 2.7%
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $249.1M
- Cost of revenue
- $90.9M
- Gross profit
- $158.3M
- Operating expenses
- $139.8M
- Operating income
- $18.5M
- Income tax
- $5.3M
- Net income
- $6.7M
- EPS (basic)
- $1.22
- EPS (diluted)
- $1.21
Balance sheet
- Total assets
- $427.7M
- Current assets
- $106.3M
- Total liabilities
- $241.5M
- Current liabilities
- $61.9M
- Shareholders’ equity
- $186.2M
Cash flow
- Operating cash flow
- $42.8M
- Investing cash flow
- -$3.2M
- Financing cash flow
- -$41.9M
- Net cash flow
- -$2.3M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year
52-week range
- Market cap
- $574.0M
- P/E ratio
- 89.6
- EPS (diluted)
- $1.21
- Dividend yield
- 0.59%
- Shares outstanding
- 5.3M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 29, 1984
Market data by Polygon.io · prices are 15-minute delayed
At a glance
- Profitable — net income of $6.7M in FY2026.
- Revenue grew 35% from FY2022 to FY2026.
- Gross margin of 63.5%, net margin 2.7%.
- Trading 15% below its 52-week high.
- Pays a dividend yielding about 0.59% annually.
- Valued at a price-to-earnings (P/E) ratio of 89.6.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review MESA LABORATORIES INC /CO/.
Write a review
News about MESA LABORATORIES INC /CO/
News & sentiment via Polygon.io
